Neoadjuvant treatment for intermediate/high-risk...

ESMO Open 2019 / 05 Vol. 4; Iss. 3

Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an ‘option’ but an ethical obligation

Brandão, Mariana, Reyal, Fabien, Hamy, Anne-Sophie, Piccart-Gebhart, Martine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Language:
english
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2019-000515
Date:
May, 2019
File:
PDF, 297 KB
english, 2019
Conversion to is in progress
Conversion to is failed